cases | Hb (g/dL) | MCV (fL) | MCH (pg) | HbA (%) | HbA2 (%) | HbF(%) | Genotype |
---|---|---|---|---|---|---|---|
77(F:49, M:28) | 135.2 ± 14.9 | 70.6 ± 7.0 | 24.9 ± 15.3 | 82.0 ± 2.6 | 2.4 ± 0.3 | 15.5 ± 2.6 | Chinese Gγ (Aγδβ)0/βN |
8 (F:1, M:7) | 129.9 ± 8.37 | 69.1 ± 3.4 | 22.5 ± 1.4 | 86.8 ± 2.5 | 2.5 ± 0.2 | 10.6 ± 2.4 | Chinese Gγ (Aγδβ)0combined with --SEA/αα |
1(M) | 155 | 77.9 | 24.1 | 86.1 | 2.7 | 1.2 | Chinese Gγ (Aγδβ)0combined with -α3.7/αα |
1(F) | 126 | 81 | 26 | 82.1 | 2 | 15.9 | Chinese Gγ (Aγδβ)0combined with -α4.2/αα |
1(M) | 137 | 74.7 | 23.1 | 83.6 | 2.7 | 13.7 | Chinese Gγ (Aγδβ)0 combined withααWS/αα |
1(M) | 128 | 64.8 | 20.3 | 16.0 | 2.7 | 81.3 | Chinese Gγ (Aγδβ)0/β−28 |
50(F:23,M:27) | 137.8 ± 14.0 | 76.6 ± 4.3 | 25.1 ± 1.5 | 74.2 ± 4.2 | 4.0 ± 0.6 | 21.8 ± 4.8 | SEA-HPFH/βN |
3(F:1,M:2) | 130.0 ± 11.1 | 69.5 ± 0.6 | 22.2 ± 0.2 | 76.4 ± 4.1 | 3.7 ± 0.5 | 19.9 ± 4.1 | SEA-HPFH/βN combined with --SEA/αα |
5(F:2,M:3) | 115.33 ± 23.75 | 66.73 ± 6.02 | 20.53 ± 2.76 | 86.26 ± 2.63 | 6.83 ± 0.57 | 6.9 ± 3.1 | Taiwanese deletion/βN |
37(F:15,M:22) | 147.8 ± 14.6 | 88.7 ± 5.0 | 29.6 ± 2.1 | 85.0 ± 1.4 | 1.8 ± 0.2 | 14.9 ± 2.3 | Aγ-196 C-T mutation |
14(F:7,M:7) | 128.3 ± 18.9 | 68.3 ± 4.2 | 21.7 ± 1.2 | 83.4 ± 2.4 | 1.4 ± 0.1 | 13.8 ± 1.5 | Aγ-196 C-T mutation combined with --SEA/αα |
1(F) | 117 | 69.2 | 22.1 | 70 | 4.1 | 25.9 | Aγ-196C-T mutation combined with --SEA/αα and β−28/βN |
1(F) | 114 | 67.7 | 21.4 | 70 | 1.6 | 16.6 | Homozygote for Aγ-196C-T mutation combined with --SEA/αα |
1(M) | 163 | 84 | 29.4 | 82.2 | 2.3 | 15.5 | Homozygote for Aγ-196C-T mutation |
1(M) | 148 | 72.4 | 23.1 | 88.8 | 2.1 | 9.1 | Aγ-197 C-T mutationcombined with --SEA/αα |
1(F) | 108 | 72.8 | 23.8 | 77.2 | 2.3 | 11.30 | Hb Lepore-Boston/Washington |